SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Park, M-C
Right arrow Articles by Lee, S-K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, M-C
Right arrow Articles by Lee, S-K
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy

M-C Park

Division of Rheumatology, Department of Internal Medicine, Institute for Immunology and Immunologic Diseases, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea

Y-B Park

Division of Rheumatology, Department of Internal Medicine, Institute for Immunology and Immunologic Diseases, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea, yongbpark{at}yumc.yonsei.ac.kr

S Y Jung

Division of Rheumatology, Department of Internal Medicine, Institute for Immunology and Immunologic Diseases, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea

I H Chung

Division of Rheumatology, Department of Internal Medicine, Institute for Immunology and Immunologic Diseases, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea

K H Choi

Division of Nephrology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea

S-K Lee

Division of Rheumatology, Department of Internal Medicine, Institute for Immunology and Immunologic Diseases, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea

This study was designed to investigate the risk of ovarian failure and the pregnancy outcomes in women treated with intravenous cyclophosphamide (IVCYC) pulse therapy for lupus nephritis. Sixty-seven women with proliferative lupus nephritis were studied. The clinical and laboratory data, SLEDAI and damage indices at IVCYC initiation, doses and numbers of IVCYC pulses, pregnancy and fetal outcomes were evaluated. During a follow-up of 74.4 + 20.6 months, amenorrhea occurred in 25 (37.3%) and was sustained permanently in 10 patients (14.9%). Thirteen women became pregnant with a total of 19 pregnancies. Seventeen pregnancies ended without complications and all babies were born healthy without any congenital anomalies or perinatal illnesses. Two pregnancies were terminated by induced abortion but no congenital anomaly was noted in these cases. Logistic regression analysis showed that old age, high damage index at the initiation of IVCYC pulse therapy and high cumulative dosage of IVCYC were the independent risk factors of ovarian failure, and that the presence of amenorrhea, regardless of its duration, was the risk factor of pregnancy failure. Pregnancy was possible with a favorable outcome after the withdrawal of IVCYC pulse therapy, unless amenorrhea develops.

Key Words: amenorrhea • cyclophosphamide • lupus nephritis • ovarian failure • pregnancy

Lupus, Vol. 13, No. 8, 569-574 (2004)
DOI: 10.1191/0961203304lu1063oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
ReproductionHome page
R A Anderson, W H B Wallace, and D T Baird
Ovarian cryopreservation for fertility preservation: indications and outcomes
Reproduction, December 1, 2008; 136(6): 681 - 689.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
C B Driver, M Ishimori, and M H Weisman
The B cell in systemic lupus erythaematosus: a rational target for more effective therapy
Ann Rheum Dis, October 1, 2008; 67(10): 1374 - 1381.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
C.A.A. Silva and H.I. Brunner
Review: Gonadal functioning and preservation of reproductive fitness with juvenile systemic lupus erythematosus
Lupus, August 1, 2007; 16(8): 593 - 599.
[Abstract] [PDF]


Home page
LupusHome page
C.A.A. Silva, M.O. Hilario, M.V. Febronio, S.K. Oliveira, M.T. Terreri, S.B. Sacchetti, F.R. Sztajnbok, R. Marini, M.V. Quintero, B.E. Bica, et al.
Risk factors for amenorrhea in juvenile systemic lupus erythematosus (JSLE): a Brazilian multicentre cohort study
Lupus, July 1, 2007; 16(7): 531 - 536.
[Abstract] [PDF]


Home page
Nephrol Dial TransplantHome page
N. C. T. Kong
Pregnancy of a lupus patient--a challenge to the nephrologist
Nephrol. Dial. Transplant., February 1, 2006; 21(2): 268 - 272.
[Full Text] [PDF]


Home page
LupusHome page
A. Raptopoulou, P. Sidiropoulos, and D. T Boumpas
Ovarian failure and strategies for fertility preservation in patients with systemic lupus erythematosus
Lupus, December 1, 2004; 13(12): 887 - 890.
[PDF]



Advertisement